![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 34, 23996-24006, August 20, 1999
,
,
,
,

From the
Department of Medical Biochemistry,
University of Gothenburg, SE-405 30 Gothenburg, Sweden, the
§ Department of Biology, Åbo Akademi University, Turku
20520, Finland, the ¶ Department of Anatomy and Cell Biology,
University of Gothenburg, SE-405 30 Gothenburg, Sweden, the
Danish Center for Human Genome Research, Aarhus 8000, Denmark,
and the ** Turku Centre for Biotechnology, University of Turku and Åbo
Akademi University, Turku 20520, Finland
| |
ABSTRACT |
|---|
|
|
|---|
Intermediate filaments are general constituents
of the cytoskeleton. The function of these structures and the
requirement for different types of intermediate filament proteins by
individual cells are only partly understood. Here we have addressed the
role of specific intermediate filament protein partnerships in the formation of intermediate filaments in astrocytes. Astrocytes may
express three types of intermediate filament proteins: glial fibrillary
acidic protein (GFAP), vimentin, and nestin. We used mice with targeted
mutations in the GFAP or vimentin genes, or both, to study the impact
of loss of either or both of these proteins on intermediate filament
formation in cultured astrocytes and in normal or reactive astrocytes
in vivo. We report that nestin cannot form intermediate
filaments on its own, that vimentin may form intermediate filaments
with either nestin or GFAP as obligatory partners, and that GFAP is the
only intermediate filament protein of the three that may form filaments
on its own. However, such filaments show abnormal organization.
Aberrant intermediate filament formation is linked to diseases
affecting epithelial, neuronal, and muscle cells. Here we present
models by which the normal and pathogenic functions of intermediate
filaments may be elucidated in astrocytes.
Intermediate filaments
(IFs)1 represent the least
understood part of the cytoskeleton. These 10-nm thin structures form
an interconnected scaffolding-like network within the cell cytoplasm. IFs are composed of different IF proteins, depending on the cell type,
the developmental stage, and in some cases also on the functional status of a given cell (1). This can be well demonstrated in astrocytes, in which three IF proteins may be found: nestin, vimentin, and glial fibrillary acidic protein (GFAP). Nestin and vimentin are the
main IF proteins in immature astroglial cells, whereas maturing and
adult astrocytes contain vimentin and GFAP. Nestin production is
resumed, and vimentin and GFAP expression is up-regulated in activated
astrocytes in reactive gliosis accompanying, e.g., trauma,
tumor growth, or neurodegenerative diseases affecting the CNS (2,
3).
The reasons for the existing diversity of IF proteins remain an enigma
as much as the functions of IFs themselves. Analyses of animal and
human mutations affecting IFs have in the recent years brought some
insight into general and specific functions of IFs, at least in some
cell types. Keratin IFs in the epithelial cells constituting the
epidermis have been shown to confer mechanical resistance to the skin,
and a number of mutations affecting keratin genes and preventing proper
assembly of IFs have been shown to be associated with human skin
blistering diseases. Thus, mutations affecting K5 or K14, the keratin
pair expressed in the basal layer of the epidermis, lead to
epidermolysis bullosa simplex, and mutations in K1 or K10, the keratins
in the adjacent spinous layers, result in epidermolytic hyperkeratosis
(1, 4-6). Neurofilaments, the IFs of neuronal cells, seem to modulate
axonal caliber (7-12). Desmin, which forms IFs in muscle cells, has
been shown to be crucial for long term structural maintenance of all
three types of muscles (13-17). The functions of GFAP remain
incompletely understood even though recent findings suggest GFAP
involvement in the long term maintenance of the brain architecture
(18), proper function of blood-brain barrier (18, 19), and modulation
of some neuronal functions by astrocytes (20, 21). We also propose that
GFAP and vimentin are required for the proper formation of a glial scar
following trauma to the central nervous system (22). Generation of
transgenic mouse models lacking one or several IF proteins has proven
to be a powerful way to learn more about the functions of IFs in
different cell types, and these models have clearly broadened the
experimental possibilities available.
It has been shown that IFs are often composed of two or more IF
proteins, which co-polymerize with each other. For example, IF
formation in epithelial cells requires the co-polymerization of two
types of keratins, one basic and one acidic (5). Similarly, experiments
performed with non-neuronal IF-free cell lines transfected with
expression vectors for individual neurofilament proteins (NF-L, NF-M,
or NF-H), or experiment with transgenic mice have demonstrated the need
for specific partnerships in the assembly of IFs; NF-L/NF-M or
NF-L/NF-H co-expression both led to IF formation, while homopolymeric
assembly of any single neurofilament protein or NF-M/NF-H co-assembly
did not result in IF formation (23, 24). It remains to be established
whether a co-polymerization of different IF proteins is a more general
prerequisite in IF formation.
By crossing GFAP-deficient mice (25) with vimentin-deficient mice (26),
we have now generated mice that lack both GFAP and vimentin. Using
these mice, we have studied the impact of the absence of GFAP and/or
vimentin on the production of IFs in normal or reactive astrocytes
in vivo and in astrocyte cultures and determined the
obligatory partnership between GFAP, vimentin, and nestin.
Preparation of Astrocyte-enriched Cultures from Whole Brain
All mice used were hybrids between C57BL/6 and 129 mouse strains
and they were generated within the same litters to equalize genetic
variation between the groups. Mice at postnatal days 1-2 were killed
by decapitation, and primary astrocyte-enriched cultures were prepared
and maintained as described previously (27).
Histology and Immunostaining
Mouse brains were fixed in Bouin's fixative (75 ml of saturated
picric acid, 5 ml of glacial acetic acid, 25 ml of 40% formaldehyde), paraffin-embedded, and serially sectioned in the frontal plane. Selected sections were stained with hematoxylin and erythrosin or
processed for immunohistochemistry. Pretreatment of the sections and
immunohistochemical staining for GFAP and vimentin was performed as
described elsewhere (25). For nestin immunostaining, slides were
incubated with nestin rabbit antiserum (a kind gift from Dr. U. Lendahl, Karolinska Institute, Stockholm, Sweden), then with
horseradish peroxidase-conjugated goat antiserum against rabbit
immunoglobulins (Dako A/S), and processed further for
3'-diaminobenzidine tetrahydrochloride staining as described previously
(25). For immunocytochemical detection of IF proteins, sparse astrocyte cultures 5 days following plating grown on 30-mm glass discs were used.
Immunostaining for GFAP and vimentin with 3'-diaminobenzidine tetrahydrochloride detection was performed as described in Ref. 27; for
nestin immunodetection, polyclonal rabbit antibody (nestin antiserum 6, described below) was used with the consecutive steps performed as
described in Ref. 27.
Electron Microscopy
For the Ultrastructural Studies in Vivo--
For the
ultrastructural studies in vivo, 2 wild type, 2 GFAP For the Ultrastructural Evaluation of IFs in Vivo--
For the
ultrastructural evaluation of IFs in vitro, 10-day-old
primary astrocytic cultures were used. Medium was removed, and the
cultures in 24-well Falcon plates were rinsed three times with isotonic
phosphate buffer. The wells were filled with the fixative consisting of
a mixture of 2% paraformaldehyde and 2% glutaraldehyde dissolved in
an isotonic phosphate buffer. The cultures were kept in the fixative
overnight at 6 °C, osmicated for 2 h, treated en
bloc for 2 h with 2% uranyl acetate dissolved in 50%
ethanol in water, dehydrated in a graded series of ethanol, and
embedded, still in the wells, in Epon. After polymerization, the
specimens were freed from the wells and sectioned as described above.
Quantitative Evaluation of the Density of IFs--
The
quantitative evaluation of the density of IFs was performed on electron
micrographs (magnification, ×100,000). An IF bundle was defined as
more than three IFs running in parallel with a distance of less than 40 nm between them. The number of IFs in transversally sectioned IFs
bundles was determined in wild type and vimentin Brain Injury Experiments
Anesthetized animals were wounded by the introduction of a
27-gauge fine needle through the skull and the frontal brain cortex as
described previously (25). The animals were killed 3, 4, 7, or 14 days after the injury; brains were carefully dissected out of the
skull, fixed in Bouin's fixative, and processed for histology
and immunohistochemistry.
SDS-PAGE and Immunoblotting
Primary astrocyte-enriched cultures were prepared from wild type
(3 mice), GFAP [35S[reset]Methionine Labeling, 32P
Labeling, and Two-dimensional Protein Electrophoresis of Cultured
Cells
[35S[reset]Methionine Labeling--
Primary
astrocyte cultures grown in 25-cm2 flasks were labeled for
14 h with [35S]methionine in 2 ml of modified
Eagle's medium lacking methionine and containing 2% dialyzed (against
0.95% NaCl) fetal calf serum and 250 µCi of
[35S]methionine (SJ 204, Amersham Pharmacia Biotech). At
the end of the labeling period, the monolayers were resuspended in 0.4 ml of lysis solution (31) and 20 µl applied to the first dimension gel.
32P Labeling--
Cultures of astrocytes or human
ear fibroblasts were labeled with [32P]orthophosphate as
described previously (32).
Cytoskeleton Preparation and Two-dimensional Protein
Electrophoresis--
Following [35S]methionine labeling,
the cultures were washed with Hanks' buffered saline and treated for
90 s with 0.1% Triton X-100 in the same buffer. After washing
with Hanks' solution, the cytoskeletal fraction was resuspended in the
lysis buffer (31). Two-dimensional PAGE was carried out according to
Ref. 31.
Northern Blot Analyses
Total RNA was prepared from wild type, GFAP Vimentin Cannot Form IFs in the Absence of GFAP in Astrocytes in
the Normal Adult Mouse Brain--
Using two different vimentin
antibodies, immunohistochemical examination of the presence of GFAP and
vimentin was performed on brain sections covering two areas that
normally contain astrocytes strongly positive for these IF
proteins: corpus callosum and hippocampus. In the corpus callosum of
wild type mice, three cell types could be distinguished that were
vimentin-positive: astrocytes, endothelial cells of brain capillaries,
and ependymal cells (Fig. 1a).
Vimentin immunoreactivity (IR) was lost in astrocytes of the corpus
callosum in GFAP GFAP Forms Abnormal IF Bundles in the Absence of Vimentin in
Astrocytes in Normal Mouse CNS--
In contrast to the loss of
vimentin-IR in GFAP Vimentin and Nestin Protein Levels and Vimentin Phosphorylation Are
Not Influenced by GFAP Absence in Astrocytes in Culture--
Primary
astrocytes in culture produce GFAP, vimentin and nestin. Since
vimentin-IR was lost in GFAP
Phosphorylation is the major mechanism regulating the assembly and
disassembly of IFs. To compare vimentin phosphorylation in wild type
and GFAP Abnormal IF Bundles in Vimentin Nestin Cannot Form IFs in GFAP Vimentin-IR Depends on Temporary Expression of Nestin in Reactive
GFAP Using mice deficient for GFAP and/or vimentin as a model system,
we found that a particular combination of IF proteins was required for
normal IF production in astrocytes. The data presented here enable us
to propose specific prerequisites for IF partnerships in astrocytes.
These are outlined in Fig. 11 and
discussed below.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
, 2 vimentin
/
, and 2 GFAP
/
vim
/
mice were used. The mice were
anesthetized with Avertin intraperitoneally. After a vascular rinse
with 100 ml of Tyrode's solution through the left ventricle, the mice
were perfused with a mixture of 2% paraformaldehyde and 2%
glutaraldehyde dissolved in isotonic phosphate buffer. Each animal
received 250 ml of the fixative infused over a period of 20 min. The
brains were removed, and 500-µm-thick slices were cut from the corpus
callosum, hippocampus, or cervical spinal cord. The slices were
postfixed over night at 6 °C, osmicated for 4 h, dehydrated in
a graded series of acetone, and embedded in Vestopal W (Fluka Chemie,
Liechtenstein). Sections (80 µm thick) were cut on an LKB Ultrotome,
picked up on Formvar-coated one-hole copper grids, contrasted first
with uranyl acetate and then with lead citrate, and examined in a
Philips EM 400 electron microscope.
/
astrocytes
in vivo by counting the IFs inside randomly placed circles
(radius of 1 or 2 cm corresponding to 100-200 nm). The distance
between individual IFs in longitudinally sectioned IF bundles was
determined in wild type and vimentin
/
astrocytes both in
vivo and in vitro. The distance was calculated by
subtracting the thickness of IFs within the bundle (n × 10 nm) from the width of the bundle and dividing this number by
n
1 (the number of IFs within the bundle diminished
by 1), i.e. the formula was: the distance between
IFs = (bundle width
10n)/n
1.
/
vim+/+ (2 mice), GFAP
/
vim+/
(3 mice), vim
/
GFAP+/
(2 mice), and GFAP
/
vim
/
(3 mice) as described above. The cultures were used 10 days following plating on 10-cm Falcon
plates, and they were in the exponential phase of their growth as
determined by cell count in parallel cultures. Whole cell extracts were
prepared by lysing cells in SDS-lysis buffer (20 mM
Tris-HCl, pH 7.2, 5 mM EGTA, 5 mM EDTA, 10 mM sodium pyrophosphate, 1% SDS, 1 mM
phenylmethylsulfonyl fluoride, 10 mg/ml antipain, 10 mg/ml leupeptin,
and 10 mg/ml pepstatin). Cells were harvested by scraping, boiled for
2-5 min, and sonicated for 15 s with a probe sonicator. Proteins
were separated on SDS-polyacrylamide gels (SDS-PAGE; Ref. 28). Gels
were stained with Coomassie Brilliant Blue to control for equal
loading. For quantitative Western immunoblotting, protein samples were
transferred from gels to nitrocellulose membranes (Schleicher & Schuell) using a Bio-Rad semidry transfer apparatus. Cytoskeletal
proteins were detected using monoclonal antibodies against actin (N350,
Amersham Pharmacia Biotech) and GFAP (691102, ICN). For vimentin
detection a polyclonal rabbit vimentin antibody 264 (29) was used.
Nestin was detected using a polyclonal rabbit antibody (nestin
antiserum 6) raised against a nestin fusion protein according to a
previously described protocol (30). When tested with Western blotting,
nestin antiserum 6 recognized specifically the nestin fusion protein
and the 220-kDa nestin band in whole cell extract of ST15A cells. The
nestin immunoreactivity pattern was identical with that observed with
the previously described nestin antiserum 130 (30). Secondary
antibodies used for immunoblotting were peroxidase-labeled sheep
anti-mouse immunoglobulins (NA 931, Amersham Pharmacia Biotech) and
peroxidase-labeled donkey anti-rabbit immunoglobulins (W401B, Promega).
The binding of antibodies to proteins was visualized by enhanced
chemiluminescence using an ECL Western blotting detection kit (Amersham
Pharmacia Biotech). The relative intensities of the protein bands on
immunoblots were analyzed by computer-assisted video-based
densitometry. Statistical analysis of the relative intensities was
performed by one-way analysis of variance, followed by Newman-Keuls
multiple comparison test by using the Prism program package (GraphPad
Software, Inc.).
/
, vimentin
/
,
and GFAP
/
vim
/
primary astrocyte cultures using the LiCl/urea method (33) and processed on formaldehyde gels according to standard
protocols. The murine nestin cDNA (a gift from Dr. Martha Marvin,
National Institutes of Health, Bethesda, MD) was labeled using
[32P]dCTP and the Megaprime labeling kit (Amersham
Pharmacia Biotech). The nestin mRNA was detected and quantified
using a Storm 820 PhosphorImager (Molecular Dynamics).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
mice, while both endothelial and ependymal cells
remained vimentin-positive (Fig. 1c). A similar loss of
vimentin-IR was found in the hippocampus of GFAP
/
mice (Fig. 1,
e and g). We have previously shown that the
hippocampus of GFAP
/
mice contains a normal number of astrocytes
(25). Thus, the loss of vimentin-positive cells in this region does not
reflect a loss of astrocytes. Ultrastructural examination of astrocytes
showed complete lack of IFs in corpus callosum and hippocampus in
GFAP
/
mice (Fig. 2,
b and d), while IFs were readily identified in
astrocytes in the same locations in wild type mice
(Fig. 2, a and c).

View larger version (141K):
[in a new window]
Fig. 1.
GFAP or vimentin immunoreactivity in wild
type, GFAP
/
, or vimentin
/
mice. Vimentin immunostaining in
corpus callosum reveals astrocytes, endothelial cells, and ependymal
cells in wild type mice (a) but only endothelial and
ependymal cells in GFAP
/
mice (c). In the hippocampus,
vimentin-IR is present in astrocytes of the wild type mice
(e), but is absent in GFAP
/
mice (g). No
difference in GFAP-IR in the corpus callosum or hippocampus was
observed between wild type and vimentin
/
mice (b,
d, f, and h). The sections were
counterstained with 50-fold diluted hematoxylin and erythrosin. The
dentate gyrus of the hippocampus is depicted by an
interrupted line; full
arrows, astrocytes; arrowheads, endothelial
cells; empty arrows, ependymal cells lining the
ventricle. Bar, 40 µm.


View larger version (324K):
[in a new window]
Fig. 2.
Electron micrographs of astrocytes in
situ. a, b, and e,
corpus callosum; c, d, and f,
hippocampus, concave aspect of dentate gyrus. In wild type mice
(a and c), the astrocytic cytoplasm
(A) contains distinct bundles of IFs (asterisks).
In GFAP
/
mice (b and d), the astrocytic
cytoplasm is devoid of IFs. In vimentin
/
mice (e and
f), the astrocytic cytoplasm contains densely packed IFs
(asterisks). Spinal cord, segment C6-7, the dorsal
funiculus (g-j). Loose bundles of IFs in wild type mice
(g) contrast with more compacted bundles of IFs in
vimentin
/
mice (i). No IFs were detected in GFAP
/
or
GFAP
/
vim
/
mice (h and j). The micrographs
were chosen as representative of 40 or more astrocytic cell bodies
examined for each of the genotypes and anatomical locations.
A, astrocytic cytoplasm; M, myelinated nerve
fiber; N, astrocytic nucleus; C, capillary;
P, cellular processes of the surrounding neuropile;
e, endoplasmic reticulum; g, Golgi apparatus;
x, myelinoid body; arrows, mitochondria;
A1 and A2, two bordering astrocytic
profiles.
/
astrocytes, GFAP-IR was retained at normal
intensity and distribution in vimentin
/
astrocytes in corpus
callosum and the hippocampus (Fig. 1, d and h
versus b and f). Ultrastructurally,
however, vimentin
/
astrocytes at these locations exhibited bundles
of IFs that were consistently more condensed than in the wild type mice
(Fig. 2, e and f). This compact appearance of the
bundles of IFs was also observed in the astrocytes of the white matter of the spinal cord of vimentin
/
mice (compare with normal IFs in
wild type mice and with the absence of IFs in GFAP
/
or
GFAP
/
vim
/
mice; Fig. 2, g-j). Quantitative
comparison between wild type and vimentin
/
astrocytes performed in
the white matter of the spinal cord revealed that in vimentin
/
astrocytes the number of IFs per area within a bundle was increased on
average to 155% with the distance between individual IFs being reduced
by 58% (Fig. 3, Table
I).

View larger version (209K):
[in a new window]
Fig. 3.
Electron micrographs of transversally or
longitudinally sectioned IF bundles in astrocytes in vivo.
Astrocytes in vimentin
/
mice (b and d)
contain more densely packed IFs than in wild type mice (a
and c) with the distance between adjacent IFs being
substantially reduced. These examples are taken from the dorsal
funiculus of the cervical spinal cord; the astrocytes were more than 50 µm away from the pial surface. Mi, mitochondrion.
Quantitative comparison of the density of IFs within IF bundles in wild
type and vim
/
astrocytes
/
astrocytes, we used primary cultured
cells to address the issue of IF protein levels. We have previously
reported that such cultures of astrocytes prepared from wild type and
GFAP
/
mice exhibit normal patterns of immunoreactivity using
vimentin or nestin antibodies, although, at the ultrastructural level,
GFAP
/
astrocytes contained reduced numbers of IFs (27). To find out
whether vimentin or nestin production were influenced quantitatively by
the absence of GFAP, we compared the levels of the two IF proteins in
primary astrocyte-enriched cultures prepared from wild type or
GFAP
/
mice. Western blot analysis from exponentially growing
cultures showed that neither vimentin nor nestin levels were altered in
the absence of GFAP (Fig. 4).

View larger version (41K):
[in a new window]
Fig. 4.
Steady state levels of IF proteins in primary
astrocytes of different genotypes. Cellular proteins were
extracted by adding SDS lysis buffer to primary astrocytes derived from
mice with variable degree of IF protein deficiency. A,
extracted proteins were separated by 7.5% SDS-PAGE and equal loading
of protein was confirmed by Coomassie Brilliant Blue staining.
B, immunoblotting of the SDS-PAGE-separated whole cell
proteins, isolated primary astrocyte cultures, with actin, GFAP,
vimentin, and nestin antibodies. Decreased nestin levels were observed
in GFAP+/
vim
/
and in GFAP
/
vim
/
cultures as compared with
the wild type, GFAP
/
, or GFAP
/
vim+/
cultures. Actin levels
remained unaltered in all cultures, and were used as internal controls.
C, quantitative analysis of the immunoblots showed 80-90%
decrease of nestin levels in GFAP+/
vim
/
or GFAP
/
vim
/
cultures (**, p < 0.01) but unaltered levels of
vimentin and GFAP in GFAP
/
and vim
/
cultures, respectively, as
compared with protein levels in wild type cultures.
/
astrocytes, we have performed 32P labeling of
primary cultures followed by two-dimensional gel electrophoresis. As
shown in Fig. 5, no differences were
detected in vimentin phosphorylation between wild type and GFAP
/
astrocytes (Fig. 5, A and B). As expected, no
phosphorylated vimentin was found in vimentin
/
or GFAP
/
vim
/
astrocytes (Fig. 5, C and D). A comparison
between mouse astrocytes and human fibroblasts showed that the pools of
phosphorylated and non-phosphorylated vimentin in two cell types are of
a comparable size (Fig. 6,
A-D).

View larger version (129K):
[in a new window]
Fig. 5.
Isoelectric focusing two-dimensional PAGE of
[32P]orthophospate-labeled proteins from astrocytes
in vitro. Comparable amount of phosphovimentin was detected
in wild type (A) and GFAP
/
(B) astrocytes.
Phosphovimentin is absent in vimentin
/
(C) and
GFAP
/
vim
/
(D) astrocytes.

View larger version (80K):
[in a new window]
Fig. 6.
Isoelectric focusing two-dimensional PAGE of
[35S]methionine-labeled proteins from mouse astrocytes
and human fibroblasts. A and B, whole
protein extracts from wild type mouse astrocytes (A) and
human fibroblasts (B). C and D, Triton
X-100-extracted cytoskeletal fractions from wild type mouse astrocytes
(C) and human fibroblasts (D). Comparable amounts
of vimentin and phosphovimentin were present in the two cell types. The
positions of vimentin, phosphovimentin, GFAP,
-tubulin, and actin
are indicated.
/
Astrocytes and Lack of IFs in
GFAP
/
vim
/
Astrocytes in Culture--
To further address the
effects of depletion of GFAP and/or vimentin on the production and
assembly of the remaining IF proteins, we studied astrocyte-enriched
cultures from wild type, GFAP
/
, vimentin
/
, and
GFAP
/
vim
/
mice. Immunocytochemical staining of nestin in wild
type or GFAP
/
astrocytes showed typical arrangement of IF bundles
(Fig. 7, a and b),
while astrocytes from either vimentin
/
or GFAP
/
vim
/
astrocytes exhibited only a diffuse pattern of weak nestin-IR, lacking
any bundle arrangement (Fig. 7, c and d). GFAP-IR
on vimentin
/
astrocytes exhibited a pattern similar to the wild
type (Fig. 7, e and f). At the ultrastructural level, distinct IFs were present in wild type and in GFAP
/
astrocytes; in the latter case, their density was reduced in accordance
with previous findings (Fig. 8,
a and b; Ref. 27). In vimentin
/
astrocytes,
IFs were present in highly compacted bundles (Fig. 8c). The
average distance between individual IFs in vimentin
/
astrocytes was
reduced more than 3-fold (Table I). This abnormal appearance of IF
bundles was never observed in wild type or GFAP
/
astrocytes. No IFs
were observed in the GFAP
/
vim
/
astrocytes (Fig. 8d),
a finding compatible with the absence of a typical filamentous
nestin-IR in these astrocytes (Fig. 7d). In agreement with
these data, quantification of nestin levels in primary cultures of
astrocytes from vimentin
/
or GFAP
/
vim
/
mice by Western blotting showed decreased amount of nestin to 10-20% of the levels in
wild type cultures (Fig. 4). In contrast, nestin mRNA levels in
vimentin
/
or GFAP
/
vim
/
astrocytes were up-regulated more than 3-fold compared with the wild type or GFAP
/
astrocytes (Fig.
9). The lower nestin protein level in the
absence of vimentin is therefore a posttranscriptional phenomenon, and
it is conceivable that this reflects more rapid degradation of
unpolymerized nestin. Moreover, the increased levels of nestin mRNA
in vimentin-deficient cells suggest the existence of a feedback that
increases the nestin transcription levels when nestin cannot polymerize
into IFs.

View larger version (117K):
[in a new window]
Fig. 7.
Immunolocalization of nestin or vimentin in
wild type, GFAP
/
, vimentin
/
, and GFAP
/
vim
/
astrocytes
in vitro. Nestin immunoreactivity reveals
distinct bundles of IFs in wild type or GFAP
/
astrocytes
(a and b) in contrast to vimentin
/
or
GFAP
/
vim
/
astrocytes, which exhibit only a very weak and
diffuse nestin immunoreactivity (c and d). GFAP
immunostaining of wild type and vimentin
/
astrocytes reveals
similar distinctly filamentous staining patterns (e and
f). Arrowheads in c and d
depict cell borders. Bar, 10 µm.

View larger version (164K):
[in a new window]
Fig. 8.
Electron micrographs of cytoplasm of wild
type, GFAP
/
, vimentin
/
, or GFAP
/
vim
/
astrocytes
in vitro. Characteristic bundles of IFs
(asterisks) in the cytoplasm in wild type astrocytes
(a). IFs are sparse in GFAP
/
astrocytes (b;
inset shows scattered IFs at higher magnification,
thin arrows). In vimentin
/
astrocytes, IFs
are present in the form of highly contrasted, densely packed bundles
(c; x, dense bundles of IFs; inset
shows details of a bundle of densely packed IFs). No IFs are present in
GFAP
/
vim
/
astrocytes (d; inset shows
detail of the cytoplasm with microtubules). The micrographs were chosen
as representative of 30 astrocytic cell bodies examined for each of the
four genotypes. IFs in a-c are 9-10 nm thick.
Mi, mitochondrion; thick arrows,
endoplasmic reticulum and/or cluster of ribosomes;
arrowheads, microtubules.

View larger version (67K):
[in a new window]
Fig. 9.
Northern blot analysis of a total RNA from
wild type, GFAP
/
, vimentin
/
, and GFAP
/
vim
/
astrocytes
in vitro using nestin cDNA as a probe. An
autoradiogram (top) is shown in comparison with an ethidium
bromide-stained gel (bottom); 50 µg of total RNA was
loaded, and the positions of the nestin band (6.2 kb) as well as the 28 and 18 S rRNA are indicated. Vimentin
/
and GFAP
/
vim
/
astrocytes contained more than 3 times higher levels of nestin mRNA
compared with wild type or GFAP
/
astrocytes.
/
vim
/
Reactive Astrocytes in
Vivo--
Fine needle injury in the frontal cortex of wild type,
GFAP
/
, vimentin
/
, or GFAP
/
vim
/
mice followed by nestin
immunohistochemical detection 3 days later, revealed distinct nestin-IR
in cortical astrocytes surrounding the defect in wild type or GFAP
/
mice (Fig. 10, a and
b). However, in the injured cortex of vimentin
/
or
GFAP
/
vim
/
mice, normal nestin-IR was absent and was replaced by
a weak and diffuse signal (Fig. 10, c and d)
similar to the nestin-IR observed in vimentin
/
or GFAP
/
vim
/
astrocytes in vitro (Fig. 7, c and d).
These results imply that also following a CNS trauma in
vivo, nestin IFs cannot form in vimentin
/
or GFAP
/
vim
/
mice. No difference was detected in GFAP-IR of cortical astrocytes in
the injured area in wild type and vimentin
/
mice (Fig. 10,
e and f). This is in agreement with the normal
GFAP-IR observed in vimentin
/
astrocytes in vitro (Fig.
7, e and f).

View larger version (142K):
[in a new window]
Fig. 10.
Reactive astrocytes in cortical lesions in
GFAP
/
, vimentin
/
, or GFAP
/
vim
/
mice. Astrocytes in
cortical lesions 3 days following the injury (a-f). Nestin
immunostaining reveals distinct reactive astrocytes in wild type or
GFAP
/
mice (a and b). In the corresponding
areas in vimentin
/
or GFAP
/
vim
/
mice, only weak and diffuse
astrocytic profiles are depicted as nestin-immunoreactive; the
situation closely resembling nestin immunoreactivity in cultured
astrocytes of the same genotype (Fig. 7, c and d)
and indicating absence of IFs. GFAP immunostaining reveals distinct
reactive astrocytes in the injured cortex of both wild type and
vimentin
/
mice (e and f). Vimentin and nestin
immunoreactivity 2 weeks following the injury (g-j). In
cortical lesions in both wild type and GFAP
/
mice, nestin
immunostaining becomes almost undetectable 2 weeks after the injury
(g and h). While normal vimentin immunostaining
persists at the site of injury in wild type mice and permits an easy
identification of individual reactive astrocytes (i), in
GFAP
/
mice, vimentin immunostaining is limited to the central zone
of the injury and has a diffuse character; endothelial cells are
clearly stained but astrocytic profiles cannot be distinguished. The
sections in g and h were counterstained with
50-fold diluted hematoxylin and erythrosin. Arrows,
astrocytes; arrowheads, endothelial cells. Bar,
10 µm (a-f) and 20 µm (g-j).
/
Astrocytes in Vivo--
Reactive astrocytes in
vivo, similar to primary astrocytes in culture, produce GFAP,
vimentin, and nestin. In some regions of the CNS, nestin-IR persists
for months following mechanical injury (3). In contrast, we found that,
in reactive wild type cortical astrocytes, nestin-IR was transient and
became undetectable 2 weeks following injury, while both GFAP-IR and
vimentin-IR were still readily detected at this time point (data not
shown). Since these "late" reactive astrocytes seem to retain
expression of vimentin and GFAP only, we asked whether vimentin-IR
persists also in the GFAP
/
mice at time points when nestin-IR has
disappeared. To address this, we performed fine needle injury of the
brain in wild type and GFAP
/
mice, followed by GFAP, vimentin, and nestin immunohistochemical staining 3, 4, 7, or 14 days later. We
detected vimentin and nestin-IR in astrocytes in the injured cortex of
both wild type and GFAP
/
mice at 3, 4, and 7 days following the
injury (data not shown), but at 14 days nestin-IR was virtually
undetectable in both wild type and GFAP
/
mice (Fig. 10,
g and h). Immunostaining with vimentin antibodies
performed 14 days after the injury revealed positive reaction in both
astrocytes and endothelial cells of the forming glial scar in the
cortex of wild type mice (Fig. 10i). However, in the
GFAP
/
mice, no distinctly stained astrocytes were seen, although
both vimentin-positive endothelial cells and additional diffuse
immunostaining were detectable (Fig. 10, compare j with
i). These results show that vimentin-IR in reactive
astrocytes can be detected as long as nestin is present. When the
transient nestin expression declines in reactive GFAP
/
astrocytes,
these cells lose their normal vimentin staining pattern, probably
because vimentin under these conditions is incapable of forming IFs on
its own.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (31K):
[in a new window]
Fig. 11.
Partnerships of IF proteins in astrocytes;
present examples.
Possible Partnerships--
Vimentin-GFAP and vimentin-GFAP-nestin
partnerships result in the productive formation of IFs, and these
partnerships represent the usual situations in unchallenged astrocytes
in the adult and in reactive astrocytes in vivo (or in
astrocytes in vitro), respectively. As shown in GFAP
/
primary astroglial cultures (this study and Ref. 27) and in reactive
gliosis in vivo in GFAP
/
mice (this study), the
vimentin-nestin partnership is also possible. This finding
is not surprising since such a partnership most probably occurs during
astrocyte maturation, prior to the onset of the GFAP expression.
An Abnormal Partnership--
Data from vimentin
/
astrocytes
in vivo and in vitro show that GFAP can form IFs
on its own. However, the arrangement of these, apparently intact,
GFAP-GFAP filaments is abnormal; instead of the usual loose
bundles, compact bundles are formed with 60-70% less space between
individual filaments. We speculate that the presence of these abnormal
bundles of IFs in vimentin
/
mice may lead to altered mechanical
properties of the vimentin
/
astrocytes (e.g. increased
cell rigidity) or have other negative effects. The concept that an
aberrant IF system is more detrimental to a cell than the complete
absence of IFs has been proposed. Skin blistering appeared milder in
those cases of epidermolysis bullosa simplex, both in humans and in
mouse models, where null rather than dominant mutations in keratin 14 gene were present (1). Abnormal accumulation and disorganization of
neurofilaments are present in a number of motorneuron diseases, such as
sporadic amyotrophic lateral sclerosis, infantile spinal muscular
atrophy, and hereditary sensory motor neuropathy as well as in
transgenic mice overexpressing neurofilament proteins (1, 34).
Recently, mice overexpressing human GFAP were generated, and they
exhibit hypertrophic astrocytes with inclusion bodies resembling
Rosenthal fibers of human neuropathology and consisting of IFs and
other aggregated proteins. The severe phenotype of these mice is
reminiscent of Alexander's disease (35).
Our finding of normal GFAP-IR but abnormally bundling GFAP IFs in
vimentin
/
astrocytes contradicts that of Galou and co-workers (36),
who report absence of GFAP-IR in astrocytes in some areas of the
cerebrum and cerebellum, and in wounding-induced reactive gliosis in
vimentin
/
mice. Curiously, the ultrastructural analysis of
cerebellum revealed variable presence of IFs; while the authors failed
to identify IFs in some astrocytes, they saw abundant IFs in other
astrocytes (36). Moreover, Galou et al. reported that the
cytoskeletal fraction of vimentin
/
astrocytes contained a normal
level of GFAP, which seems inconsistent with the loss of GFAP IFs. We
consistently detected astrocytic IFs in vimentin
/
mice in all areas
of the CNS examined, i.e. corpus callosum, hippocampus, and
white matter of the spinal cord. We also show that the IFs in
vimentin
/
astrocytes consistently formed compacted bundles, both in
the intact CNS and in astrocytes in culture. Like Galou et
al., we find that the levels of GFAP protein are not decreased in
vimentin
/
astrocytes. Taken together, therefore, biochemical and
ultrastructural analysis favor our interpretation that GFAP may
assemble into IF networks in the absence of vimentin.
Impossible Partnerships--
As shown both in the unchallenged
brain in GFAP
/
mice and in later stages of reactive gliosis in the
brain cortex, vimentin-vimentin partnership does not result
in the production of IFs (Fig. 7). Instead, to form normal IFs,
vimentin needs a partner, which may be either nestin or GFAP. If such a
concept is generally applicable to astrocytes throughout the CNS, it
would imply that, to have IFs, astrocytes or their precursors would
have to express either nestin (astroglial precursors) or GFAP (mature
astrocytes) at any given vimentin-positive stage of their development.
In the light of the common view that vimentin may form IFs on its own at least in selected cell types, it is possible that either the astrocyte environment has a major effect on IF assembly, or that in
some cell types, other IF-associated proteins such as synemin and
paranemin (37) can enable vimentin self-polymerization either by
stabilizing the IF network or by acting directly as IF proteins (38).
Vimentin phosphorylation, which could potentially be responsible for
cell-type specific differences in the assembly of IFs, was found to be
comparable in wild type and GFAP
/
astrocytes as well as in normal
human fibroblasts. It is therefore unlikely that the degree of vimentin
phosphorylation in astrocytes depends on GFAP or differs substantially
from other cell types.
Similarly, nestin-nestin or nestin-GFAP
partnerships are non-productive as far as the formation of IFs is
concerned. As shown by the data from reactive gliosis in vimentin
/
or GFAP
/
vim
/
mice or from primary astrocyte cultures, nestin
cannot form IFs on its own or with GFAP. This is a surprising finding;
while no cell type at any developmental or activation stage has been
known to co-express GFAP and nestin in the absence of other IF
proteins, it has not previously been ruled out that at least some cells of neuroectodermal origin are exclusively nestin-positive during the
early developmental stages. It remains to be shown whether the
inability of nestin to form IFs applies generally to different cell
types or is restricted to reactive astrocytes. Some support for the
former comes from the finding that endothelial cells, which are
normally vimentin- and nestin-positive, lose their nestin-IR in
vimentin
/
or GFAP
/
vim
/
mice (22). Also, it was recently reported that nestin fails to assemble into IFs when introduced into
the IF-free SW13 cell line, but it forms IFs there if vimentin is
present (39). Perhaps the most important implication of the inability
of nestin to form IFs on its own lies in the fact the GFAP
/
vim
/
mice have their astrocytes devoid of IFs both in the unchallenged as
well as in the reactive state. These mice therefore provide a model to
study the relevance of IF up-regulation in the context of reactive
gliosis of different origin and for the evaluation of a potential role
of this phenomenon in the pathogenesis of a number of disease conditions.
New Insights into the Functions of IFs in Astrocytes--
We still
do not understand the functions of IFs in astrocytes, although it seems
probable that, besides putative functions that are unique to individual
IF proteins or combination thereof, astrocytic as well as other IFs
have a general function in the maintenance of mechanical integrity of
cells and tissues. High content of IFs as seen in reactive astrocytes
and in certain populations of non-reactive astrocytes (such as in
corpus callosum, hippocampus, cerebellum, or white matter of the spinal
cord) may represent a functional state for which IFs may be
particularly important. Alterations in long term depression in the
cerebellum and an impaired eye-blink reflex have been reported in
GFAP
/
mice (20), as have changes in long term potentiation in the
hippocampus (21). This suggests that astrocytes normally modulate
neuronal functions and that these activities are dependent on IFs.
Formation of the blood-brain barrier represents a typical result of
inductive signaling between astrocytes and endothelial cells of
capillaries in the CNS. In the absence of GFAP, the blood-brain barrier
was found to be impaired both regionally in vivo (18) and
could not be reconstituted in a model system in vitro (19).
However, until now the importance of IF up-regulation in reactive
gliosis could not be evaluated since a suitable in vivo
model was lacking. The GFAP
/
vim
/
mice clearly represent such a
model since their astrocytes can not form or up-regulate IFs in the
context of reactive gliosis. Our recent data suggest that the ability
of reactive astrocytes to up-regulate IFs following CNS injury is
crucial for CNS wound healing.
In conclusion, we have described the impact of GFAP and/or vimentin
absence on IF formation in astrocytes. Our results reveal requisite IF
protein partnerships for IF formation in normal and reactive
astrocytes. We also suggest that mice lacking both GFAP and vimentin
are well suited to address the importance of IF up-regulation in
different conditions that trigger reactive gliosis since these mice
fail to produce astrocytic IFs.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Charles Babinet and Dr. Emma Colucci-Guyon for providing the vimentin null mice, Dr. Charles Babinet and Dr. Alain Privat for valuable discussions, Ulrika Wilhemsson for genotyping some of the animals, and Marianne Eriksson and Rita Grandér for technical help with processing the cultures for electron microscopy. Dr. Emma Colucci-Guyon and Dr. Urban Lendahl are acknowledged for providing vimentin and nestin antibodies, respectively, and Dr. Martha Marvin for the gift of nestin cDNA.
| |
FOOTNOTES |
|---|
* This work was supported by Swedish Medical Research Council Projects 11548, 09041, and 03157; Swedish Cancer Foundation Project 3622; a fellowship from the Swedish Society for Medical Research (to M. P.); and grants from the Swedish Society for Medicine, the Swedish Society for Medical Research, the King Gustaf V Foundation, A+ Science Invest, Inga-Britt and Arne Lundberg Foundation, Göran Gustafsson Foundation, the Academy of Finland, and Turku Graduate School in Biomedical Sciences.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom all correspondence should be addressed: Dept. of
Medical Biochemistry, University of Gothenburg, Box 440, SE-405 30 Gothenburg, Sweden. Fax: 46-31-416108; E-mail:
Milos.Pekny@medkem.gu.se.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: IF, intermediate filament; GFAP, glial fibrillary acidic protein; CNS, central nervous system; PAGE, polyacrylamide gel electrophoresis; IR, immunoreactivity.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Fuchs, E.,
and Cleveland, D. W.
(1998)
Science
279,
514-519 |
| 2. | Eng, L. F., and Ghirnikar, R. S. (1994) Brain Pathol. 4, 229-237[Medline] [Order article via Infotrieve] |
| 3. |
Frisén, J.,
Johansson, C. B.,
Török, C.,
Risling, M.,
and Lendahl, U.
(1995)
J. Cell Biol.
131,
453-464 |
| 4. | Quinlan, R., Hutchison, C., and Lane, B. (1994) Protein Profile 1, 779-911[Medline] [Order article via Infotrieve] |
| 5. | Fuchs, E. (1995) Annu. Rev. Cell Devel. Biol. 11, 123-153[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Quinlan, R., Hutchison, C., and Lane, B. (1995) Protein Profile 2, 795-952[Medline] [Order article via Infotrieve] |
| 7. |
Ohara, O.,
Gahara, Y.,
Miyake, T.,
Teraoka, H.,
and Kitamura, T.
(1993)
J. Cell Biol.
121,
387-395 |
| 8. | Eyer, J., and Peterson, A. (1994) Neuron 12, 389-405[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Côté, F., Collard, J. F., and Julien, J. P. (1993) Cell 73, 35-46[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Xu, Z., Cork, L. C., Griffin, J. W., and Cleveland, D. W. (1993) Cell 73, 23-33[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Collard, J. F., Côté, F., and Julien, J. P. (1995) Nature 375, 61-64[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Marszalek, J. R.,
Williamson, T. L.,
Lee, M. K.,
Xu, Z.,
Hoffman, P. N.,
Becher, M. W.,
Crawford, T. O.,
and Cleveland, D. W.
(1996)
J. Cell Biol.
135,
711-724 |
| 13. | Li, Z., Colucci-Guyon, E., Pincon-Raymond, M., Mericskay, M., Pournin, S., Paulin, D., and Babinet, C. (1996) Dev. Biol. 175, 362-366[CrossRef][Medline] [Order article via Infotrieve] |
| 14. |
Milner, D. J.,
Weitzer, G.,
Tran, D.,
Bradley, A.,
and Capetanaki, Y.
(1996)
J. Cell Biol.
134,
1255-1270 |
| 15. | Thornell, L., Carlsson, L., Li, Z., Mericskay, M., and Paulin, D. (1997) J. Mol. Cell Cardiol. 29, 2107-2124[CrossRef][Medline] [Order article via Infotrieve] |
| 16. |
Li, Z.,
Mericskay, M.,
Agbulut, O.,
Butler-Browne, G.,
Carlsson, L.,
Thornell, L. E.,
Babinet, C.,
and Paulin, D.
(1997)
J. Cell Biol.
139,
129-144 |
| 17. | Capetanaki, Y., Milner, D. J., and Weitzer, G. (1997) Cell Struct. Funct. 22, 103-116[Medline] [Order article via Infotrieve] |
| 18. | Liedtke, W., Edelman, W., Bieri, P. L., Chiu, F. C., Cowan, N. J., Kucherlapati, R., and Raine, C. S. (1996) Neuron 17, 607-615[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Pekny, M., Stanness, K., Eliasson, C., Betsholtz, C., and Janigro, D. (1998) Glia 22, 390-400[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Shibuki, K., Gomi, H., Chen, L., Bao, S., Kim, J. J., Wakatsuki, H., Fujisaki, T., Fujimoto, K., Katoh, A., Ikeda, T., Chen, C., Thompson, R. F., and Itohara, S. (1996) Neuron 16, 587-599[CrossRef][Medline] [Order article via Infotrieve] |
| 21. |
McCall, M. A.,
Gregg, R. G.,
Behringer, R. R.,
Brenner, M.,
Delaney, C. L.,
Galbreth, E. J.,
Zhang, C. L.,
Pearce, R. A.,
Chiu, S. Y.,
and Messing, A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
6361-6366 |
| 22. |
Pekny, M.,
Johansson, C.,
Eliasson, C.,
Stakeberg, J.,
Wallén, Å,
Perlmann, T.,
Lendahl, U.,
Betsholtz, C.,
Berthold, C.-H.,
and Frisén, J.
(1999)
J. Cell Biol.
145,
503-514 |
| 23. |
Ching, G. Y.,
and Liem, R. K.
(1993)
J. Cell Biol.
122,
1323-1335 |
| 24. |
Lee, M. K.,
Xu, Z.,
Wong, P. C.,
and Cleveland, D. W.
(1993)
J. Cell Biol.
122,
1337-1350 |
| 25. | Pekny, M., Levéen, P., Pekna, M., Eliasson, C., Berthold, C.-H., Westermark, B., and Betsholtz, C. (1995) EMBO J. 14, 1590-1598[Medline] [Order article via Infotrieve] |
| 26. | Colucci-Guyon, E., Portier, M. M., Dunia, I., Paulin, D., Pournin, S., and Babinet, C. (1994) Cell 79, 679-6 |